C1QTNF3 and cardiovascular disorder: Further experimental and prospectively-designed studies should be performed to clarify the influences of these two novel adipokines, progranulin and CTRP3, on the pathogenesis and outcomes of chronic metabolic disorders and cardiovascular disease.